{{Cite journal| doi = 10.23736/S2724-6507.21.03564-8| issn = 2724-6116 (Electronic) 2724-6116 (Linking)| volume = 48| issue = 3| pages = 346–359| last1 = Papaefthymiou| first1 = A.| last2 = Doulberis| first2 = M.| last3 = Karafyllidou| first3 = K.| last4 = Chatzimichael| first4 = E.| last5 = Deretzi| first5 = G.| last6 = Exadaktylos| first6 = A. K.| last7 = Sampsonas| first7 = F.| last8 = Gelasakis| first8 = A.| last9 = Papamichos| first9 = S. I.| last10 = Kotronis| first10 = G.| last11 = Gialamprinou| first11 = D.| last12 = Vardaka| first12 = E.| last13 = Polyzos| first13 = S. A.| last14 = Kountouras| first14 = J.| title = Effect of spironolactone on pharmacological treatment of nonalcoholic fatty liver disease| journal = Minerva Endocrinol (Torino)| date = 2021-10-21| pmid = 34669319}}